checkAd
    Startseite > Aktien > PharmaTher Holdings > Nachrichten
    PharmaTher Holdings Aktie
    0,1650
     
    USD
    -2,31 %
    -0,0039 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: CA71716H1082 · WKN: A3CM5J · SYM: PHRRF · Kanada

    Neueste Nachrichten

    PharmaTher’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
    15.05.24 · globenewswire · PharmaTher Holdings
    PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug Application for Ketamine
    10.05.24 · globenewswire · PharmaTher Holdings
    PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
    01.05.24 · globenewswire · PharmaTher Holdings
    PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
    18.04.24 · globenewswire · PharmaTher Holdings
    PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
    16.04.24 · globenewswire · PharmaTher Holdings
    PharmaTher’s Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia
    21.02.24 · globenewswire · PharmaTher Holdings
    PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
    12.02.24 · globenewswire · PharmaTher Holdings
    PharmaTher Provides Update for Expected FDA Approval of Ketamine
    10.01.24 · globenewswire · PharmaTher Holdings
    PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX (Ketamine)
    27.09.23 · globenewswire · PharmaTher Holdings
    PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX (Ketamine) to the FDA
    06.09.23 · globenewswire · PharmaTher Holdings
    PharmaTher Announces Positive Research Results for PharmaPatch with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics
    18.07.23 · globenewswire · PharmaTher Holdings
    PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX (racemic ketamine) to the FDA
    27.06.23 · globenewswire · PharmaTher Holdings